Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karla Zemanová is active.

Publication


Featured researches published by Karla Zemanová.


Journal of Leukocyte Biology | 1999

Retinoid X receptor suppresses transformation by the v-myb oncogene

Jan Šmarda; Karla Zemanová; Josef Bryja; Jana Šmardová; Alois Kozubík; Jiřina Hofmanová; Alice Nemajerova; Sabina Ševčíková; Jiří Kohoutek; Petr Vodička

The v‐myb oncogene of avian myeloblastosis virus causes acute monoblastic leukemia in vivo and transforms myelomonocytic cells in culture. Retinoids are potent regulators of proliferation and differentiation in various cell types, and they can initiate differentiation in certain types of leukemic cells. However, the BM2 v‐myb‐trans‐formed chicken monoblastic cell line is resistant to retinoic acid treatment. We found that overexpression of the retinoid X receptor confers sensitivity of BM2 cells to retinoic acid, resulting in induction of growth arrest and terminal differentiation. In contrast, the frequency of apoptosis was not affected by the retinoid X receptor in this cell type. We also demonstrated that suppression of transformation by v‐Myb results from the negative effect of retinoid X receptor on v‐Myb transactivation function, similar to that previously described for the retinoic acid receptor. The retinoid X receptor‐induced inhibition of transactivation by v‐Myb seems to be enhanced by a cell type‐specific factor(s), which is not required by retinoic acid receptor. J. Leukoc. Biol. 66: 1039–1048; 1999.


Blood Cells Molecules and Diseases | 1998

ONCOPROTEIN V-MYB AND RETINOIC ACID RECEPTOR ALPHA ARE MUTUAL ANTAGONISTS

Karla Zemanová; Jan Šmarda


Archive | 2000

Srovnání anti-onkogenních vlastností retinoidových receptorůRAR a RXR.

Lucie Horová; Karla Zemanová; Josef Bryja; Jana Šmardová; Sabina Ševčíková; Petr Vodička; Jiří Kohoutek; Jan Šmarda


Archive | 1999

Overproduction and purification of CBP for antibody preparation

Jana Šmardová; Alice Nemajerova; Karla Zemanová; Jan Šmarda


Archive | 1999

Activated retinoid receptors suppress the v-myb oncogene

Jan Šmarda; Karla Zemanová; Josef Bryja; Sabina Ševčíková; Lucie Horová; Jana Šmardová; Jiří Kohoutek; Petr Vodička


Klinická biochemie a metabolismus | 1999

Antileukemické účinky proteinu RXR

Josef Bryja; Karla Zemanová; Jan Šmarda


Archive | 1998

Retinoid X receptor alpha suppresses v-Myb transformation

Karla Zemanová; Josef Bryja; Jan Šmarda


Archive | 1998

Both RAR and RXR proteins can reverse v-myb transformation

Lucie Horová; Karla Zemanová; Sabina Ševčíková; Jan Šmarda


Archive | 1998

Retinoic X receptor suppresses v-myb transformation

Lucie Horová; Karla Zemanová; Josef Bryja; Jana Šmardová; Sabina Ševčíková; Jiří Kohoutek; Jan Šmarda


Klinická biochemie a metabolizmus | 1998

Onkoprotein v-Myb zabraňuje apoptóze buněk HL-60 vyvolanépůsobením kyseliny retinové

Karla Zemanová; Jan Šmarda

Collaboration


Dive into the Karla Zemanová's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jana Šmardová

Royal Bournemouth Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jiřina Hofmanová

Academy of Sciences of the Czech Republic

View shared research outputs
Researchain Logo
Decentralizing Knowledge